Home › Funds › PLUSTICK MANAGEMENT LLC › MRNA
PLUSTICK MANAGEMENT LLC position in MRNA
MODERNA INC · Health Care
PLUSTICK MANAGEMENT LLC reported holding 219,000 shares of MRNA (MODERNA INC) in its Q3 2026 13F filing — a position valued at US$42.2M, representing 17.50% of its reported portfolio and ranking #1 among its reported holdings. PLUSTICK MANAGEMENT LLC has disclosed MRNA holdings in 7 of the last 7 reported quarters, going back to Q1 2025.
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
How PLUSTICK MANAGEMENT LLC's MRNA position evolved
PLUSTICK MANAGEMENT LLC first disclosed a stake in MRNA in Q1 2025 at 70,000 shares (US$2.0M). The position peaked in Q3 2026 at 219,000 shares, worth US$42.2M. Across 7 filings, PLUSTICK MANAGEMENT LLC increased the stake 4 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 219,000 shares valued at US$42.2M — a reduction of -26,000 shares quarter over quarter.. Notable position changes include a 50% increase in Q3 2025 (shares rose 14% over the following quarter), a 117% increase in Q4 2025 (shares rose 72% over the following quarter), a 69% increase in Q1 2026 (shares rose 38% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2025 | 70.00K | $1.98M | New |
| Q2 2025 | 40.00K | $1.10M | Reduce |
| Q3 2025 | 60.00K | $1.55M | Add |
| Q4 2025 | 130.00K | $3.83M | Add |
| Q1 2026 | 220.00K | $11.18M | Add |
| Q2 2026 | 245.00K | $17.16M | Add |
| Q3 2026 | 219.00K | $42.17M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About MRNA and 13F data
MRNA (MODERNA INC) is a Health Care company. 42 other funds we track also report a position in MRNA — the largest reported positions include Fidelity Management & Research (FMR) (US$11.35B), Capital World Investors (US$4.36B), Baillie Gifford & Co (US$2.20B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding MRNA
- Fidelity Management & Research (FMR) 58.96M sh · $11.35B · Q3 2026
- Capital World Investors 22.64M sh · $4.36B · Q3 2026
- Baillie Gifford & Co 11.44M sh · $2.20B · Q3 2026
- Theleme Partners LLP 6.66M sh · $1.28B · Q3 2026
- IMC-Chicago, LLC 3.07M sh · $590.92M · Q3 2026
- Merck & Co., Inc. 2.31M sh · $444.49M · Q3 2026
- BANQUE PICTET & CIE SA 2.15M sh · $414.27M · Q3 2026
- Flagship Pioneering, LLC 4.63M sh · $324.39M · Q2 2026
- a16z Perennial Management, L.P. 1.52M sh · $292.57M · Q3 2026
- Douglas Lane & Associates, LLC 1.16M sh · $223.56M · Q3 2026
- Beau Ventures, LLc 1.00M sh · $192.58M · Q3 2026
- Lingotto Investment Management LLP 749.21K sh · $144.27M · Q3 2026
More on PLUSTICK MANAGEMENT LLC
FAQ
How long has PLUSTICK MANAGEMENT LLC held MRNA?
PLUSTICK MANAGEMENT LLC has disclosed MRNA holdings in 7 of the last 7 reported quarters, going back to Q1 2025.
What is PLUSTICK MANAGEMENT LLC's current position in MRNA?
As of Q3 2026, PLUSTICK MANAGEMENT LLC holds 219.00K shares of MRNA (MODERNA INC), valued at $42.17M, representing 17.50% of its reported portfolio and ranking #1.
Has PLUSTICK MANAGEMENT LLC been buying or selling MRNA?
In the latest 13F filing (Q3 2026), PLUSTICK MANAGEMENT LLC reduced its position in MRNA. The position peaked in Q3 2026 at 219.00K shares.
Which other funds hold MRNA?
Other major institutional holders of MRNA include Fidelity Management & Research (FMR), Capital World Investors, Baillie Gifford & Co, among 42 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.